Letter by Lee regarding article, matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute stroke

Stroke

Volumn 42, Issue 10, 2011, Pages

  Lee, Regent ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MINOCYCLINE;

ACUTE DISEASE; ACUTE ISCHEMIC STROKE; BLOOD SAMPLING; BRAIN ISCHEMIA; DRUG EFFECT; ENZYME IMMUNOASSAY; HUMAN; INTERNAL VALIDITY; LETTER; MACROPHAGE; MEASUREMENT; PRIORITY JOURNAL; THROMBOCYTE;

EID: 80053312693     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.632869     Document Type: Letter

References (4)

1. Switzer JA, Hess DC, Ergul A, Waller JL, Machado LS, Portik-Dobos V, et al. Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. [published online ahead of print July 7 2010] Stroke. 2011 http://stroke.ahajournals.org/content/early/2011/07/07/ STROKEAHA.111.618215. Accessed July 13 2011.
2. Mannello F, Jung K, Tonti GA, Canestrari F. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood. Clin Biochem. 2008;41:1466-1473.
3. Jung K, Klotzek S, Stephan C, Mannello F, Lein M. Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9. Clin Chem. 2008;54:772-773.
4. Mannello F. Serum or plasma samples? The "cinderella" role of blood collection procedures: Preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. Arterioscler Thromb Vasc Biol. 2008;28:611-614. (Pubitemid 351651318)